- Home
- CGBD vs CRMD Comparison
CGBD vs CRMD Comparison
Compare CGBD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGBD
- CRMD
- Stock Information
- Founded
- CGBD 2012
- CRMD 2006
- Country
- CGBD United States
- CRMD United States
- Employees
- CGBD N/A
- CRMD 82
- Industry
- CGBD Finance: Consumer Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CGBD Finance
- CRMD Health Care
- Exchange
- CGBD Nasdaq
- CRMD Nasdaq
- Market Cap
- CGBD 1.0B
- CRMD 865.2M
- IPO Year
- CGBD 2017
- CRMD 2010
- Fundamental
- Price
- CGBD $13.32
- CRMD $11.12
- Analyst Decision
- CGBD Hold
- CRMD Strong Buy
- Analyst Count
- CGBD 5
- CRMD 8
- Target Price
- CGBD $14.63
- CRMD $17.57
- AVG Volume (30 Days)
- CGBD 406.9K
- CRMD 4.6M
- Earning Date
- CGBD 11-04-2025
- CRMD 10-29-2025
- Dividend Yield
- CGBD 12.54%
- CRMD N/A
- EPS Growth
- CGBD N/A
- CRMD N/A
- EPS
- CGBD 1.14
- CRMD 0.79
- Revenue
- CGBD $234,464,000.00
- CRMD $121,484,498.00
- Revenue This Year
- CGBD $15.09
- CRMD $404.81
- Revenue Next Year
- CGBD $6.01
- CRMD $56.11
- P/E Ratio
- CGBD $11.85
- CRMD $14.00
- Revenue Growth
- CGBD N/A
- CRMD 14970.29
- 52 Week Low
- CGBD $13.12
- CRMD $5.60
- 52 Week High
- CGBD $18.64
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CGBD 34.07
- CRMD 34.64
- Support Level
- CGBD $13.22
- CRMD $12.73
- Resistance Level
- CGBD $13.91
- CRMD $13.83
- Average True Range (ATR)
- CGBD 0.22
- CRMD 0.81
- MACD
- CGBD -0.05
- CRMD -0.30
- Stochastic Oscillator
- CGBD 12.82
- CRMD 0.90
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.